Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Any impact of pre-operative radiotherapy on renal function in retroperitoneal soft tissue sarcomas? A secondary ancillary analysis of the EORTC 62092 STRASS 1 trial.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026

Same author

Redefining radiotherapy: the gut as an active target in Immuno-Oncology.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Same author

Safety and efficacy of concurrent radiation therapy with amivantamab in patients with advanced EGFR- or MET-altered non-small cell lung cancer.

European journal of cancer (Oxford, England : 1990)·2026

Same author

Clinical trial endpoints for metastases-directed therapy in oligometastatic cancer: a review and Delphi consensus on behalf of the EORTC-ESTRO OligoCare consortium.

The Lancet. Oncology·2026

Same author

Unusual Case of Neuromeningeal Late Relapse of POLE Mutated Endometrioid Carcinoma: A Case Report and Systematic Review.

Current oncology (Toronto, Ont.)·2026

Same author

Practice-changing clinical trials in radiation oncology: A 2024-2025 literature synthesis.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026

Same journal

Contribution of fluorodeoxyglucose positron-emission tomography combined with magnetic resonance imaging for differential diagnosis between radionecrosis and recurrence of treated brain metastasis.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026

Same journal

Comparative study of interstitial brachytherapy and intensity-modulated radiotherapy as tumour bed boost after conservative surgery for breast cancer: Toxicity and cosmetic outcomes.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026

Same journal

White paper on radiotherapy in France: Ten objectives to strengthen one of the major modalities of cancer treatment.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026

Same journal

Contemporary survival outcomes of patients with isolated nodal recurrences of breast cancer: A population-based study.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026

Same journal

Factors affecting the stability of deep inspiration breath-holding in radiotherapy for left-sided breast cancers.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026

Same journal

Incidence and outcomes of radiation-induced sarcomas following radiotherapy for low-grade non-Hodgkin lymphomas: A population-based study.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jan 11, 2026

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

Radiotherapy for lung metastases.

Antonin Levy¹, Marion Tonneau², Julien Darréon³

¹Université Paris-Saclay, Gustave Roussy, Département d'Oncologie-Radiothérapie, Villejuif, France; Université Paris-Saclay, faculté de Médecine, Le Kremlin-Bicêtre, France; Université Paris-Saclay, Inserm U1030, Gustave Roussy, Villejuif, France.

Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique

|November 12, 2025

Summary

This summary is machine-generated.

Stereotactic body radiotherapy offers promising local control and survival for select patients with limited pulmonary metastases. These updated French Society for Radiation Oncology guidelines detail its use and alternatives for lung cancer treatment.

Keywords:

Guidelines Intrathoracic metastases Lung oligometastases Metachronous Métachrone Métastases pulmonaires Oligometastases pulmonaire Oligométastatique radiothérapie Recommandations Recommendations Réglementation SABR SFRO Société française de radiotherapie oncologique Stereotactic radiotherapy Stéréotaxique Synchrone Synchronous

More Related Videos

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Related Experiment Videos

Last Updated: Jan 11, 2026

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Area of Science:

Oncology
Radiation Oncology

Background:

Pulmonary metastases are common across various cancers.
Systemic treatments are standard, but local therapies show promise for oligometastatic disease.

Purpose of the Study:

To provide updated French Society for Radiation Oncology (SFRO) recommendations for radiotherapy in intrapulmonary metastases.
To focus on stereotactic body radiotherapy (SBRT) indications and techniques.

Main Methods:

Review of current evidence and clinical practice for SBRT in pulmonary metastases.
Development of guidelines covering patient selection, technical aspects, and motion management.
Consideration of alternative palliative radiotherapy approaches.

Main Results:

SBRT demonstrates significant local control and survival benefits in selected patients.
Detailed criteria for patient selection, treatment planning, and dose prescription are outlined.
Guidelines address respiratory motion management and organ-at-risk constraints.

Conclusions:

Updated SFRO recommendations guide the safe and effective use of SBRT for pulmonary metastases.
SBRT is a key local therapy for oligometastatic lung disease.
Alternative hypofractionated palliative radiotherapy is recommended when SBRT is not feasible.